BioSpace News Archive

Dr. Marcus Kostka appointed CEO, Dr. Jörg Vollmer joins as CSO

Alnylam Pharmaceuticals, Inc. announced that Muthiah Manoharan, Ph.D., Senior Vice President of Drug Innovation Chemistry at Alnylam, has been awarded the 2019 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society, an open, nonprofit organization to foster academia and industry-based research and development of oligonucleotide therapeutics.

Industry thought leaders join a distinguished group of experts to advance Caris’ mission to expand the role of precision medicine in cancer care

Immunic, Inc. announced the appointment of Tamar Howson, a highly seasoned life sciences executive, to its Board of Directors, effective October 11, 2019.

Vector Smart™ products being presented at 6 vector control conferences in October to prepare for 2020 mosquito season

KSQ Therapeutics to receive non-exclusive access to certain CRISPR IP for its autologous cell therapies, including its existing eTIL™ cell franchise

Novavax, Inc. announced the initiation of a pivotal Phase 3 clinical trial for NanoFlu™, its recombinant quadrivalent seasonal influenza vaccine candidate, in adults aged 65 and over.

Neovasc, Inc. announced that the United States Patent and Trademark Office has issued US Patent No. 10,433,952, titled: “PROSTHETIC VALVE FOR AVOIDING OBSTRUCTION OF OUTFLOW”.

Emerald Health Therapeutics has received from Health Canada its cultivation license amendment and has full municipal permitting for its first of two 78,000 square foot greenhouses at its organic Metro Vancouver site in British Columbia.

Celemics, provider of NGS target enrichment kits and innovative sequencing platforms, announced the release of a comprehensive NGS target enrichment workflow for clinical and translational research applications.